Aligos Therapeutics, Inc. (ALGS) vs CervoMed Inc. (CRVO)

A side-by-side comparison of Aligos Therapeutics, Inc. and CervoMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs CRVO

growth of $100 · dividends reinvested · last 6y
ALGS -98.5% (-50.6%/yr)CRVO -94.5% (-38.3%/yr)CRVO compounded faster over this window
050100150200250Start $100202120222023202420252026$1$5
ALGS CRVO

ALGS vs CRVO: by the numbers

  • •ALGS is the larger company ($34M vs $31M market cap).
  • •Both run net losses; ALGS's is the smaller (-241.01% vs -9408.76% net margin).

Metrics side by side

Valuation

MetricALGSCRVO
P/S ratio1.0795.01
P/B ratio1.061.33

Profitability

MetricALGSCRVO
Gross margin57.46%0.00%
Operating margin-4024.93%0.00%
Net margin-241.01%-9408.76%
ROE-238.24%-132.18%
ROIC-207.97%-135.73%

Growth (annualized)

MetricALGSCRVO
Revenue CAGR (5Y)-15.85%N/A
Total return CAGR (5Y)-57.15%-38.25%

Frequently asked

How have ALGS and CRVO total returns compared?
Over the past 5 years, ALGS delivered -57.15% and CRVO delivered -38.25% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.